SEP Analytical (Shanghai) Co. Ltd. (301228) - Total Liabilities
Based on the latest financial reports, SEP Analytical (Shanghai) Co. Ltd. (301228) has total liabilities worth CN¥342.48 Million CNY (≈ $50.12 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of SEP Analytical (Shanghai) Co. Ltd. to assess how effectively this company generates cash.
SEP Analytical (Shanghai) Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how SEP Analytical (Shanghai) Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check SEP Analytical (Shanghai) Co. Ltd. liquidity resilience to evaluate the company's liquid asset resilience ratio.
SEP Analytical (Shanghai) Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of SEP Analytical (Shanghai) Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Genus Power Infrastructures Limited
NSE:GENUSPOWER
|
India | Rs35.49 Billion |
|
ChengDa Pharmaceuticals Co. Ltd.
SHE:301201
|
China | CN¥249.97 Million |
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IS:GENIL
|
Turkey | TL7.52 Billion |
|
Shanxi Guoxin Energy Co Ltd A
SHG:600617
|
China | CN¥20.60 Billion |
|
Sagicor Financial Company
TO:SFC
|
Canada | CA$23.66 Billion |
|
Zee Entertainment Enterprises Limited
NSE:ZEEL
|
India | Rs20.95 Billion |
|
Guararapes Confecções S.A
SA:GUAR3
|
Brazil | R$8.01 Billion |
|
Qinghai Jinrui Mineral Development Co Ltd
SHG:600714
|
China | CN¥79.36 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down SEP Analytical (Shanghai) Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301228 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SEP Analytical (Shanghai) Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SEP Analytical (Shanghai) Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of SEP Analytical (Shanghai) Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥337.29 Million ≈ $49.36 Million |
+4.70% |
| 2023-12-31 | CN¥322.14 Million ≈ $47.14 Million |
+17.50% |
| 2022-12-31 | CN¥274.15 Million ≈ $40.12 Million |
+18.64% |
| 2021-12-31 | CN¥231.08 Million ≈ $33.81 Million |
-1.13% |
| 2020-12-31 | CN¥233.72 Million ≈ $34.20 Million |
+52.06% |
| 2019-12-31 | CN¥153.70 Million ≈ $22.49 Million |
-- |
About SEP Analytical (Shanghai) Co. Ltd.
SEP Analytical (Shanghai) Co., Ltd. engages in the provision of third-party testing services in China. It offers soil, ground water and wastewater, seawater, solid waste, sludge, edible agricultural products, food, cosmetics, textiles, toys and children's products, occupational health, medicine, and other testing services related to human health. The company is also involved in the provision of i… Read more